ScripInvestors Demur On Roche’s Sales Growth When Roche Holding AG reiterated in its third-quarter financial results announcement its guidance for a fall in full-year 2023 sales, the press release headli
Pink SheetA proposal to equalize the commercial lifespan of small molecules and biologics at 13 years before becoming subject to Medicare price negotiation received the most attention among industry-suggested f
ScripDespite Roche Holding AG ’s troubled investment trying to compete with Pfizer Inc. in a genetically defined subpopulation of non-small cell lung cancer, Bristol Myers Squibb Company has decided t
ScripErasca Inc. and Imago BioSciences, Inc. raised the most money out of the five biopharmaceutical companies that launched initial public offerings during the first half of July, and their stocks were